ANDA 85867, held by Purepac Pharm. Secobarbital Sodium.
As of Nov 15, 2026, ANDA 85867 (Secobarbital Sodium), held by Purepac Pharm, was not approved, with 0 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Secobarbital Sodium100MG ยท capsule;oral | Secobarbital Sodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
